Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Understand the advantages of choosing no fee high cash back credit cards. Make a financially savvy choice for your wallet.
27,451 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Austria's stock rally accelerates as banks lift the EWO ETF, but the upside may be thinning as net interest margins c...
Permanent Portfolio's Michael Cuggino argues Meta can invest heavily in AI without sacrificing profits. He emphasizes...
Two financial plans, one patient retiree, and a surprising reframe: treating Social Security as a bond changes how a ...
The 2026 Social Security COLA is 2.8%, but higher-income retirees face loss due to Medicare IRMAA surcharges that swa...
Three blue-chip names have slipped on the chart while trading below intrinsic value, offering income and upside for p...
Rigetti's Q1 earnings tonight could shape the next move for its stock as Novera shipments and Cepheus milestones feed...
Mining profitability remains under pressure as hashprice tests new lows for 2026. Analysts say the bitcoin miner bott...
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...
Strategy reported a dramatic second quarter loss tied to its Bitcoin holdings, even as the company bought more BTC ov...
Kroger's margin-led growth and private-label strength are driving a re-rating away from Walmart's ad-driven model, si...
Meta Platforms surged about 6% as traders embraced a leaner AI cloud plan. Analysts say the cost-cutting framework co...